Financial

Conformal Medical Announces $9 million Series B Financing

NASHUA, N.H., Dec. 3, 2018 /PRNewswire/ — Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, has secured $9 million in Series B funding. Conformal is developing proprietary seal technology for the prevention of stroke in patients with atrial fibrillation (AFib). Over five million people in the United States have AFib, […]

Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement

VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed Consolidated Interim Financial Statements and the Management’s Discussion and Analysis for the three and nine month period ended September 30, 2018 and 2017 which are […]

Millar Announces Discontinuation of CD Leycom Distribution Agreement

HOUSTON, Nov. 29, 2018 /PRNewswire/ — Millar, Inc., medical device manufacturer and OEM innovation partner, announced today that the company will end its distribution agreement with CD Leycom, manufacturer of the clinical Inca® Pressure-Volume (PV) Loop System, on December 31, 2018. Millar has been the exclusive distributor within North America for CD Leycom since November 2013. The CD Leycom Inca […]

Reprieve Cardiovascular introduces guided diuretic therapy at major heart failure congresses

MILFORD, Massachusetts – ( BUSINESS WIRE ) – Reprieve Cardiovascular ™, a pioneering medical device company focused on improving the treatment of patients with acute decompensated heart failure (ADHF), will soon be at various well-known sites Conferences for Heart Failure represented. Reprieve-guided diuretic therapy will be the subject of the two presentations […]

Amarin to Participate in a Fireside Chat at Citi’s 2018 Global Healthcare Conference

BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 28, 2018 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin’s president and chief executive officer, is scheduled to participate in a fireside chat regarding […]

Medical Leaders Join BioSig Clinical Advisory Board

Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company formed a Clinical Advisory Board to complement existing scientific […]

Carson S. Webb, MD Joins Alaska Heart & Vascular Institute

ANCHORAGE, Alaska, Nov. 27, 2018 /PRNewswire/ — Alaska Heart & Vascular Institute (AHVI) is pleased to announce the addition of Carson S. Webb, M.D. to the Mat-Su clinic in Palmer, AK. Dr. Webb graduated with a degree in medicine from the University of South Alabama in 2000. He specializes in percutaneous coronary, peripheral arterial, and peripheral venous interventions. […]

BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies

Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Texas Cardiac Arrhythmia […]

Stereotaxis to Present at the 11th Annual LD Micro Main Event Investor Conference

ST. LOUIS, Nov. 26, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 11th Annual LD Micro Main Event investor conference. Mr. Fischel […]